ERS spotlights AI lung disease detection; employer cancer benefits; outpatient CAR T; tafasitamab response similar across races; HFpEF missed at referral.
News|Articles|July 8, 2025
Practical Considerations for AI in Community Oncology
Author(s)Mary Caffrey
Fact checked by: Laura Joszt, MA
Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Advertisement
Advertisement
Can artificial intelligence (AI) really make life better for an oncologist in day-to-day practice? Questions about AI accuracy, how to adopt technology, and who pays are consequential, given the disappointment that practices experienced with the rise of electronic health records (EHRs).
Related to this article
Geeta Nayyar, MD, MBA, says AI's real health care payoff is cutting administrative friction with clean data and clinical leadership.
Vitamin K shot refusals rose 77% from 2017 to 2024. Experts break down the drivers, risks, and how clinicians and payers should respond in 5 FAQs.
Karen van Caulil, PhD, on how employers can improve cancer care by investing in access, prevention, and support through treatment and survivorship.
Debra Patt, MD, PhD, MBA, MPH, discusses AI adoption, administrative burden, and strategies to streamline prior authorization in oncology.
Working-age adults with private insurance are paying off medical debt, often draining savings, delaying care, or cutting back on necessities as a result.
AI-assisted spirometry, imaging biomarkers, and population screening strategies highlighted early detection and prevention as a throughline at the ERS Congress.
AACR urges Congress to protect NIH/NCI funding amid a fight over a contested OMB grantmaking rule.
Advertisement
Advertisement